Henry Schein Inc

Henry Schein Inc(HSIC)股票分析

$83.970

-2.343 (-2.79%)收盘时

Loading chart…
最高
87.355
开盘
86.320
成交量加权均价
85.08
成交量
1.32M
市值
8.21B
最低
83.920
成交额
112.07M
企业价值/息税折旧摊销前利润(TTM)
11.47

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.

AI 分析 of Henry Schein Inc (HSIC)

买入

Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.

分析师评级(16)

-8.56% 下跌空间
买入
9 买入
7 持有
0 卖出
当前: 83.97
最低
58.00
平均
76.78
最高
90.00

BTIG

2026-08-19

目标价

$110

买入

Barclays

2026-08-06

目标价

$100

增持

Mizuho

2026-08-05

目标价

$86

中性

UBS

2026-08-05

目标价

$94

中性

Barrington

2026-08-05

目标价

$104

跑赢大盘

估值指标

Henry Schein Inc(HSIC)当前预期市盈率为 14.81,5 年平均预期市盈率为 15.14。

预期市盈率

合理
5 年均值 P/E
15.14
当前P/E
14.81
高估
16.64
低估
13.65

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.72
当前EV/EBITDA
11.47
高估
12.44
低估
11.00

预期市销率

合理
5 年均值 P/S
0.73
当前P/S
0.67
高估
0.83
低估
0.64

Alphio AI 对 HSIC 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%HSIC

$82.44

情景价格

基

基准

基准 · 50%HSIC

$70.37

情景价格

悲

悲观

悲观 · 25%HSIC

$57.21

情景价格

持有 HSIC 的大户

L

Lakewood Capital Management, LP

+ 持有HSIC

+5.88%

3个月收益率

E

Everett Harris & Co.

+ 持有HSIC

+4.90%

3个月收益率

S

Southpoint Capital Advisors LP

+ 持有HSIC

+2.04%

3个月收益率

L

Lyrical Asset Management LP

+ 持有HSIC

+1.34%

3个月收益率

K

KKR & Co. Inc.

+ 持有HSIC

-1.27%

3个月收益率

P

Palestra Capital Management LLC

+ 持有HSIC

-2.71%

3个月收益率

事件时间线

2026-10-08 (ET)

07:30:00

Henry Schein Appoints Emmanuel Caprais as CFO

2026-09-08 (ET)

08:30:00

Applied BioCode Signs Distribution Agreement with Henry Schein

2026-08-04 (ET)

06:30:00

2026 EPS Consensus at $5.34, Revenue Growth View Raised to 4.5%-5.5%

06:30:00

Company Reports Q2 Revenue of $3.5B, Beating Expectations

2026-07-30 (ET)

07:30:00

Henry Schein Establishes Leadership Team, Restructures Executive Management

资讯

HSIC 常见问题 —— 由 Alphio AI 解答

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易